Final ID: Su506
Teran Felipe, Doynow Daniel, De Villa Eleonora, Woo Michael, Thavanathan Rajiv, Burns Katharine, Prager Ross, Arntfield Robert, Myslik Frank, Robinson Evan, Haines Lawrence, Owyang Clark, Buchanan Brian, Jafry Zan, Sands Nathaniel, Kaviyarasu Aarthi, Abella Benjamin, Wray Trenton, Lessard Justine, Bedard Michel William, Hipskind John, Salinas Pedro, Dieiev Vladyslav, Nogueira Jonathan
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor